RENT.COM.AU LIMITED — Share Issue/Capital Change 2007

Apr 18, 2007

ASX ANNOUNCEMENT NOTICE UNDER SECTION 708A(5) OF THE CORPORATIONS ACT [ASX Code: SLT]

This notice is given under paragraph $(5)(e)$ of section 708A of the Corporations Act.

The following securities of the Company were issued without disclosure to investors under Part 6D.2 of the Corporations Act:

Type:	Shares
Class/Description:	Ordinary (fully paid)
ASX Code:	SLT.
Date of Issue:	19 April 2007
Number Issued:	29,518,072
Issue Price per Security (deemed):	A\$0.02965

The Company intends to apply to Australian Stock Exchange Limited for quotation of the above securities.

As at the date of this notice, the Company has complied with:

• (a) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and
• (b) section 674 of the Corporations Act.

Other information which is	None.
excluded information required
to be disclosed under
paragraph $(6)(e)$ of section
708A of the Corporations Act

For and on behalf of Select Vaccines Limited

Richard Wadley Secretary

19 April 2007

About Select Vaccines Limited

Select Vaccines listed on the ASX on 3 July 2003. It is developing products which identify and protect against infectious diseases of global and national importance and which satisfy the needs of other pharmaceutical and biotechnology companies. Select Vaccines' pipeline includes products targeting 'flu, hepatitis C, and Malaria. It is in partnership with Melbourne's Burnet Institute to commercialize research outcomes in the area of infectious disease. The Burnet Institute, established in 1986, is Australia's leading research organization in the field of infectious diseases caused by viruses and other agents.

Further information can be found on the company's website: www.selectvaccines.com.au.

For further information: Martin Soust (Managing Director) 03 9529 8788